Showing results (11-20 of 416) with videos related to
Sort By:
Pageof 42
Cancer Cell|December 12, 2018
BH3-Mimetic Drugs: Blazing the Trail for New Cancer MedicinesDelphine Merino, Gemma L Kelly, Guillaume Lessene, et al.Nature Reviews. Cancer|October 19, 2021
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugsSarah T Diepstraten, Mary Ann Anderson, Peter E Czabotar, et al.Oncogene|August 11, 2023
BCL-W makes only minor contributions to MYC-driven lymphoma developmentSarah T Diepstraten, John E La Marca, Catherine Chang, et al.Blood|August 25, 2018
Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical useMargs S Brennan, Catherine Chang, Lin Tai, et al.Nature Reviews. Immunology|February 19, 2005
The role of BH3-only proteins in the immune systemAndreas StrasserBlood Advances|January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell linesSarah T Diepstraten, Catherine Chang, Lin Tai, et al.Cell Reports|March 4, 2015
An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivoBrandon J Aubrey, Gemma L Kelly, Andrew J Kueh, et al.Cell Death and Differentiation|February 4, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cellsZilu Wang, Huimin Hu, Luuk Heitink, et al.Cell Death and Differentiation|December 14, 2023
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responsesJohn E La Marca, Brandon J Aubrey, Bruce Yang, et al.Viruses|November 16, 2017
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?Leah Fitzsimmons, Gemma L KellyPageof 42